Skip to main content
Fig. 6 | Cardiovascular Diabetology

Fig. 6

From: Berberine alleviates the cerebrovascular contractility in streptozotocin-induced diabetic rats through modulation of intracellular Ca2+ handling in smooth muscle cells

Fig. 6

Comparison of resting level of Ca2+ fluorescence intensity and maximal increases of Ca2+ fluorescence intensity in cerebral VSMCs isolated from CON, CON +100 mg/kg/day berberine, Diabetic, and diabetic +100 mg/kg/day berberine rats. Representative dot graph of Fluo-3/AM fluorescence recorded showed the typical transient increases of intracellular Ca2+ fluorescence intensity evoked by 10 mM caffeine (A). Summarized data indicated the average changes of the intracellular Ca2+ fluorescence intensity before and during the application of caffeine (B). Chronic administration of 100 mg/kg/day berberine significantly not only decreased the resting [Ca2+]i level, but also suppressed the Ca2+ releases from RyRs in cerebral VSMCs isolated from diabetic rats. CON control rats, CON + berberine control rats administrated with berberine (100 mg/kg/day), Diabetic diabetic rats, diabetic + berberine diabetic rats administrated with berberine (100 mg/kg/day). Values are expressed as mean ± SEM and at least n = 10 cells recorded in each group. *P < 0.05 vs. CON rats and # P < 0.05 vs. diabetic rats

Back to article page